These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33567792)

  • 1. Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy.
    Naranjo-Gomez M; Cahen M; Lambour J; Boyer-Clavel M; Pelegrin M
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33567792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies.
    Naranjo-Gomez M; Lambour J; Piechaczyk M; Pelegrin M
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.
    Michaud HA; Gomard T; Gros L; Thiolon K; Nasser R; Jacquet C; Hernandez J; Piechaczyk M; Pelegrin M
    PLoS Pathog; 2010 Jun; 6(6):e1000948. PubMed ID: 20548955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.
    Nasser R; Pelegrin M; Michaud HA; Plays M; Piechaczyk M; Gros L
    J Virol; 2010 Oct; 84(19):10169-81. PubMed ID: 20610721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential and sequential immunomodulatory role of neutrophils and Ly6C
    Lambour J; Naranjo-Gomez M; Boyer-Clavel M; Pelegrin M
    Emerg Microbes Infect; 2021 Dec; 10(1):964-981. PubMed ID: 33858301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies.
    Nasser R; Pelegrin M; Plays M; Gros L; Piechaczyk M
    Blood; 2013 Feb; 121(7):1102-11. PubMed ID: 23264590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses.
    Pelegrin M; Marsile-Medun S; Abba-Moussa D; Souchard M; Naranjo-Gomez M
    Antibodies (Basel); 2022 Jul; 11(3):. PubMed ID: 35892710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic depletion of natural killer cells controls persistent infection.
    Waggoner SN; Daniels KA; Welsh RM
    J Virol; 2014 Feb; 88(4):1953-60. PubMed ID: 24284324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines.
    Park JE; Kim SE; Keam B; Park HR; Kim S; Kim M; Kim TM; Doh J; Kim DW; Heo DS
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32830112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.
    Dong W; Wu X; Ma S; Wang Y; Nalin AP; Zhu Z; Zhang J; Benson DM; He K; Caligiuri MA; Yu J
    Cancer Discov; 2019 Oct; 9(10):1422-1437. PubMed ID: 31340937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with anti-PSMA CAR NK-92 cell and anti-PD-L1 monoclonal antibody enhances the antitumour efficacy against castration-resistant prostate cancer.
    Wang F; Wu L; Yin L; Shi H; Gu Y; Xing N
    Clin Transl Med; 2022 Jun; 12(6):e901. PubMed ID: 35696531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Metastases via Myeloid CD39 and NK Cell Effector Function.
    Yan J; Li XY; Roman Aguilera A; Xiao C; Jacoberger-Foissac C; Nowlan B; Robson SC; Beers C; Moesta AK; Geetha N; Teng MWL; Smyth MJ
    Cancer Immunol Res; 2020 Mar; 8(3):356-367. PubMed ID: 31992567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion.
    Alvarez M; Simonetta F; Baker J; Morrison AR; Wenokur AS; Pierini A; Berraondo P; Negrin RS
    Front Immunol; 2020; 11():7. PubMed ID: 32117218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells.
    Littwitz-Salomon E; Dittmer U; Sutter K
    Retrovirology; 2016 Nov; 13(1):77. PubMed ID: 27821119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.
    Capuano C; Pighi C; Battella S; De Federicis D; Galandrini R; Palmieri G
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses.
    Littwitz-Salomon E; Schimmer S; Dittmer U
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28904191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
    Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection.
    Cook KD; Kline HC; Whitmire JK
    J Leukoc Biol; 2015 Aug; 98(2):153-62. PubMed ID: 25986014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity.
    Dolina JS; Sung SS; Novobrantseva TI; Nguyen TM; Hahn YS
    Mol Ther Nucleic Acids; 2013 Feb; 2(2):e72. PubMed ID: 23423360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.